These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17520396)

  • 1. Ultrasound screening for fetal major abnormalities at 11-14 weeks.
    Dane B; Dane C; Sivri D; Kiray M; Cetin A; Yayla M
    Acta Obstet Gynecol Scand; 2007; 86(6):666-70. PubMed ID: 17520396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan.
    Souka AP; Pilalis A; Kavalakis I; Antsaklis P; Papantoniou N; Mesogitis S; Antsaklis A
    Am J Obstet Gynecol; 2006 Feb; 194(2):393-6. PubMed ID: 16458635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Fetal Structural Anomalies at 11 to 14 Weeks.
    Vayna AM; Veduta A; Duta S; Panaitescu AM; Stoica S; Buinoiu N; Nedelea F; Peltecu G
    J Ultrasound Med; 2018 Aug; 37(8):2063-2073. PubMed ID: 29476550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of congenital heart defects throughout pregnancy; impact of first trimester ultrasound screening for cardiac abnormalities.
    Eleftheriades M; Tsapakis E; Sotiriadis A; Manolakos E; Hassiakos D; Botsis D
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2546-50. PubMed ID: 22712625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of fetal structural abnormalities at the 11-14 week ultrasound scan.
    Carvalho MH; Brizot ML; Lopes LM; Chiba CH; Miyadahira S; Zugaib M
    Prenat Diagn; 2002 Jan; 22(1):1-4. PubMed ID: 11810640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of malformations in chromosomally normal fetuses by routine ultrasound at 12 or 18 weeks of gestation-a randomised controlled trial in 39,572 pregnancies.
    Saltvedt S; Almström H; Kublickas M; Valentin L; Grunewald C
    BJOG; 2006 Jun; 113(6):664-74. PubMed ID: 16709209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.
    Syngelaki A; Hammami A; Bower S; Zidere V; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):468-476. PubMed ID: 31408229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study.
    McAuliffe FM; Fong KW; Toi A; Chitayat D; Keating S; Johnson JA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1260-5. PubMed ID: 16157148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of first-trimester sonography in the diagnosis of aneuploidy and structural fetal anomalies.
    Abu-Rustum RS; Daou L; Abu-Rustum SE
    J Ultrasound Med; 2010 Oct; 29(10):1445-52. PubMed ID: 20876898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of fetuses with malformations discovered before 14 weeks. Where the discovery is revealed by echography during the first trimester, is it responsible for the voluntary termination of the pregnancy? Comparison before and after July 2001].
    Mangione R; Fries N; Godard P; Fontanges M; Haddad G; Mirlesse V;
    J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):154-62. PubMed ID: 18036748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a two-step ultrasound examination protocol for the detection of major fetal structural defects.
    Pilalis A; Basagiannis C; Eleftheriades M; Faros E; Troukis E; Armelidou E; Papastefanou I; Souka AP
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1814-7. PubMed ID: 22348739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation.
    Taipale P; Ammälä M; Salonen R; Hiilesmaa V
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1141-6. PubMed ID: 15548146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of fetal structural abnormalities by an 11-14-week ultrasound dating scan in an unselected Swedish population.
    Cedergren M; Selbing A
    Acta Obstet Gynecol Scand; 2006; 85(8):912-5. PubMed ID: 16862467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.